These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29360652)

  • 21. Hyperprolactinemic Galactorrhea Associated With Cefpodoxime in a Patient With Recurrent Depressive Disorder on Venlafaxine Monotherapy: A Case Report.
    Das N; Chadda RK
    J Clin Psychopharmacol; 2020; 40(6):635-636. PubMed ID: 33065718
    [No Abstract]   [Full Text] [Related]  

  • 22. Menstrual disturbance and galactorrhea in people taking conventional antipsychotic medications.
    Thangavelu K; Geetanjali S
    Exp Clin Psychopharmacol; 2006 Nov; 14(4):459-60. PubMed ID: 17115873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aripiprazole for the Treatment of Antipsychotic-Induced Hyperprolactinemia in an Adolescent Boy.
    Curran RL; Badran IA; Peppers V; Pedapati EV; Correll CU; DelBello MP
    J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):490-1. PubMed ID: 27120681
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hyperprolactinemia with galactorrhea induced by lansoprazole: A case report].
    Duwicquet F; Gras-Champel V; Masmoudi K
    Therapie; 2017 Dec; 72(6):691-693. PubMed ID: 29061292
    [No Abstract]   [Full Text] [Related]  

  • 25. Hormonal side effects in women: typical versus atypical antipsychotic treatment.
    Dickson RA; Seeman MV; Corenblum B
    J Clin Psychiatry; 2000; 61 Suppl 3():10-5. PubMed ID: 10724128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperprolactinemia with aripiprazole: understanding the paradox.
    Saraf G; Behere RV; Venkatasubramanian G; Rao NP; Varambally S; Gangadhar BN
    Am J Ther; 2014; 21(3):e80-1. PubMed ID: 22357167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the Effectiveness and Safety of the Addition of and Switching to Aripiprazole for Resolving Antipsychotic-Induced Hyperprolactinemia: A Multicenter, Open-Label, Prospective Study.
    Yoon HW; Lee JS; Park SJ; Lee SK; Choi WJ; Kim TY; Hong CH; Seok JH; Park IH; Son SJ; Roh D; Kim BR; Lee BO
    Clin Neuropharmacol; 2016; 39(6):288-294. PubMed ID: 27438182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefits of switching women schizophrenic patients to aripiprazole: a case study and brief review of the literature.
    Kuloglu M; Ekinci O; Albayrak Y; Caykoylu A
    Arch Womens Ment Health; 2010 Oct; 13(5):443-7. PubMed ID: 20179976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Risperidone-Associated Hyperprolactinemia With Aripiprazole.
    Mazher OA; Maneta E; Hall W
    J Clin Psychopharmacol; 2018 Oct; 38(5):529-531. PubMed ID: 30106879
    [No Abstract]   [Full Text] [Related]  

  • 30. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.
    Shim JC; Shin JG; Kelly DL; Jung DU; Seo YS; Liu KH; Shon JH; Conley RR
    Am J Psychiatry; 2007 Sep; 164(9):1404-10. PubMed ID: 17728426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperprolactinemia and amenorrhea associated with olanzapine normalized after addition of aripiprazole.
    Wolf J; Fiedler U
    J Clin Pharm Ther; 2007 Apr; 32(2):197-8. PubMed ID: 17381670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aripiprazole in a patient vulnerable to side effects.
    Dehning S; Riedel M; Müller N
    Am J Psychiatry; 2005 Mar; 162(3):625. PubMed ID: 15741488
    [No Abstract]   [Full Text] [Related]  

  • 33. [Endocrine side effects among psychiatric patients treated with antipsychotics].
    Kovács L; Kovács G
    Neuropsychopharmacol Hung; 2006 Jun; 8(2):61-6. PubMed ID: 17073213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study.
    Lee BH; Kim YK; Park SH
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):714-7. PubMed ID: 16571367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
    Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galactorrhea - side effect of risperidone in combination with depakine chrono in a patient with bipolar disorder.
    Peitl MV; Peitl V; Grahovac T; Pavlović E
    Psychiatr Danub; 2010 Mar; 22(1):125-7. PubMed ID: 20305608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug-induced hyperprolactinemia and galactorrhea].
    Bozzolo M; Haefeli WE; Noll G; Lüscher TF
    Schweiz Rundsch Med Prax; 1992 Dec; 81(50):1511-3. PubMed ID: 1465520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using aripiprazole to treat new-onset hyperprolactinemia-related delusion of pregnancy.
    Hu LY; Lee YT; Lu T; Hung MB; Hung YY
    Aust N Z J Psychiatry; 2015 Oct; 49(10):946. PubMed ID: 26101399
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of Adjunctive Aripiprazole on Sexual Dysfunction in Schizophrenia: A Preliminary Open-Label Study.
    Fujioi J; Iwamoto K; Banno M; Kikuchi T; Aleksic B; Ozaki N
    Pharmacopsychiatry; 2017 Mar; 50(2):74-78. PubMed ID: 27656915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.